American Century Companies Inc. Acquires 20,425 Shares of Proto Labs, Inc. $PRLB

Key Points

• American Century Companies Inc. has increased its shareholding in Proto Labs, Inc. by 38.8% during the first quarter, bringing its total ownership to 73,004 shares valued at approximately $2.56 million.
• Proto Labs reported a quarterly earnings of $0.41 EPS, surpassing analysts' estimates of $0.33 EPS, and reported a revenue of $135.06 million for the quarter.
• Analysts have raised their price targets for Proto Labs, with Cantor Fitzgerald upgrading their price objective to $51.00, indicating a positive outlook on the stock.

American Century Companies Inc. grew its stake in Proto Labs, Inc. (NYSE:PRLB - Free Report) by 38.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 73,004 shares of the industrial products company's stock after acquiring an additional 20,425 shares during the quarter. American Century Companies Inc. owned 0.31% of Proto Labs worth $2,558,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of PRLB. Pacer Advisors Inc. grew its position in shares of Proto Labs by 9,033.1% in the 1st quarter. Pacer Advisors Inc. now owns 148,595 shares of the industrial products company's stock valued at $5,207,000 after purchasing an additional 146,968 shares during the period. Nuveen LLC acquired a new position in shares of Proto Labs in the 1st quarter valued at approximately $2,458,000. SG Capital Management LLC acquired a new position in shares of Proto Labs in the 4th quarter valued at approximately $1,950,000. Bridgeway Capital Management LLC grew its position in shares of Proto Labs by 81.8% in the 4th quarter. Bridgeway Capital Management LLC now owns 96,359 shares of the industrial products company's stock valued at $3,767,000 after purchasing an additional 43,358 shares during the period. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in shares of Proto Labs in the 1st quarter valued at approximately $1,336,000. 84.54% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Suresh Krishna acquired 1,725 shares of the company's stock in a transaction dated Monday, August 4th. The shares were bought at an average price of $43.51 per share, for a total transaction of $75,054.75. Following the purchase, the chief executive officer directly owned 18,021 shares in the company, valued at approximately $784,093.71. This trade represents a 10.59% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 1.70% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

Several equities analysts recently issued reports on the company. Cantor Fitzgerald boosted their price objective on Proto Labs from $50.00 to $51.00 and gave the company an "overweight" rating in a research report on Friday, August 1st. Craig Hallum upgraded Proto Labs from a "hold" rating to a "buy" rating and set a $54.00 price objective for the company in a research report on Friday, August 1st. Finally, Wall Street Zen raised Proto Labs from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 2nd. Two analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $52.50.

Proto Labs Price Performance

NYSE:PRLB traded down $0.23 during trading hours on Friday, reaching $49.97. 132,116 shares of the stock were exchanged, compared to its average volume of 164,925. Proto Labs, Inc. has a twelve month low of $26.34 and a twelve month high of $51.09. The firm has a 50 day moving average of $44.29 and a 200 day moving average of $39.72. The stock has a market cap of $1.19 billion, a PE ratio of 83.28 and a beta of 1.27.

Proto Labs (NYSE:PRLB - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The industrial products company reported $0.41 earnings per share for the quarter, topping analysts' consensus estimates of $0.33 by $0.08. Proto Labs had a return on equity of 2.22% and a net margin of 2.91%.The firm had revenue of $135.06 million during the quarter, compared to the consensus estimate of $128.05 million. During the same quarter in the prior year, the firm posted $0.38 EPS. The business's revenue was up 7.6% on a year-over-year basis. Proto Labs has set its Q3 2025 guidance at 0.350-0.430 EPS. Equities research analysts anticipate that Proto Labs, Inc. will post 0.81 earnings per share for the current year.

Proto Labs Profile

Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.